Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00204_DB00880_nanopub.RA-SzCP_8gvTeu2kqFpuHcU2WabTqB3CBZZa73-WjRHUI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00204_DB00880 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00204_DB00880 label "DDI between Dofetilide and Chlorothiazide - Thiazide diuretics such as chlorothiazide may enhance the QTc-prolonging effect of dofetilide. Thiazide diuretics may increase the serum concentration of dofetilide. The concomitant use of hydrochlorothiazide and dofetilide is contraindicated by the manufacturer of dofetilide. Monitor for increased risk of QTc-prolongation and associated ventricular arrythmias during concomitant use of dofetilide and thiazide diuretics. [drugbank_resource:DB00204_DB00880]" assertion.
- drugbank_resource:DB00204_DB00880 identifier "drugbank_resource:DB00204_DB00880" assertion.
- drugbank_resource:DB00204_DB00880 title "DDI between Dofetilide and Chlorothiazide - Thiazide diuretics such as chlorothiazide may enhance the QTc-prolonging effect of dofetilide. Thiazide diuretics may increase the serum concentration of dofetilide. The concomitant use of hydrochlorothiazide and dofetilide is contraindicated by the manufacturer of dofetilide. Monitor for increased risk of QTc-prolongation and associated ventricular arrythmias during concomitant use of dofetilide and thiazide diuretics." assertion.
- drugbank:DB00204 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00204_DB00880 assertion.
- drugbank:DB00880 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00204_DB00880 assertion.